skip to Main Content
skip to Footer

Medium angle of sparkling blue, white, and gray bokeh lights or circles.

Video

European Healthcare & Life Sciences Investor Symposium 2025

December 18, 2025

Key decision-makers from across the industry gathered at Latham’s European Healthcare & Life Sciences Investor Symposium, a series of events held in Paris, London, and Frankfurt. Explore key insights from the symposium, including how to navigate global regulatory risks, spotting opportunities amid uncertainty, and strategic market outlooks.

HCLS Investor Symposium — Paris 2025

HCLS Investor Symposium — Paris 2025

Partner Jennifer Bragg on Opportunities in Policy Uncertainty

Sini Eskola, Takeda, Discusses Global Regulatory Risks

Samantha Jerusalmy, Elaia, on AI Challenges for Growth

Partner Shayne Kennedy on Tariffs and the US Market

Partner Eveline Van Keymeulen on Weathering a Geopolitical Storm

Partner Robbie McLaren Discusses Structural Shifts in HCLS

Partner Charles Ruck on Dealmaking Amid Tariffs

HCLS Investor Symposium — London 2025

HCLS Investor Symposium — London 2025

Partner Elizabeth Richards on Market Opportunities

Partner Joshua Holian Discusses Antitrust and Global Dealmaking

Partner Melanie Howard on Continuation Funds as Exit Routes

Associate Oliver Mobasser on Aligning Buyer-Seller Incentives

HCLS Investor Symposium — Frankfurt 2025

HCLS Investor Symposium — Frankfurt 2025

Counsel Jacob Fontaine on the Resilient Healthcare M&A Market

Partner Henning Schneider on the HCLS Industry Platform

Benjamin Fischer, STADA, Discusses Successful Partnerships

Partner Les Carnegie on Health Data as a National Security Asset

Henry Elphick, European Healthcare Investor Association, Shares HCLS Outlook

Deniz Tschammler on Strategic Life Sciences Partnerships

Endnotes

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.